MA50155A - Acides aminés à chaîne ramifiée pour le traitement d'une lésion neuronale - Google Patents
Acides aminés à chaîne ramifiée pour le traitement d'une lésion neuronaleInfo
- Publication number
- MA50155A MA50155A MA050155A MA50155A MA50155A MA 50155 A MA50155 A MA 50155A MA 050155 A MA050155 A MA 050155A MA 50155 A MA50155 A MA 50155A MA 50155 A MA50155 A MA 50155A
- Authority
- MA
- Morocco
- Prior art keywords
- branched
- treatment
- amino acids
- chain amino
- neuronal damage
- Prior art date
Links
- 150000005693 branched-chain amino acids Chemical class 0.000 title 1
- 230000003961 neuronal insult Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0626—Isoleucine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0628—Leucine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0634—N-Acetyl-Cysteine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0654—Valine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/30—Other Organic compounds
- A23V2250/306—Creatine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762545364P | 2017-08-14 | 2017-08-14 | |
US201862614198P | 2018-01-05 | 2018-01-05 | |
US201862697690P | 2018-07-13 | 2018-07-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA50155A true MA50155A (fr) | 2020-07-29 |
Family
ID=63449701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA050155A MA50155A (fr) | 2017-08-14 | 2018-08-14 | Acides aminés à chaîne ramifiée pour le traitement d'une lésion neuronale |
Country Status (18)
Country | Link |
---|---|
US (1) | US20190046486A1 (fr) |
EP (1) | EP3684350A1 (fr) |
JP (2) | JP7370960B2 (fr) |
KR (1) | KR20200040276A (fr) |
CN (1) | CN111295186A (fr) |
AU (1) | AU2018318091A1 (fr) |
BR (1) | BR112020002244A2 (fr) |
CA (1) | CA3072092A1 (fr) |
CL (1) | CL2020000383A1 (fr) |
CO (1) | CO2020001627A2 (fr) |
IL (1) | IL272336A (fr) |
JO (1) | JOP20200035A1 (fr) |
MA (1) | MA50155A (fr) |
MX (1) | MX2020001766A (fr) |
PE (1) | PE20200748A1 (fr) |
SG (1) | SG11202001131TA (fr) |
TW (1) | TW201919602A (fr) |
WO (1) | WO2019036442A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
CN110678172A (zh) | 2017-04-28 | 2020-01-10 | 胺细拉健康公司 | 用于治疗创伤性脑损伤的氨基酸组合物及其使用方法 |
CU20200012A7 (es) | 2017-08-14 | 2021-02-04 | Axcella Health Inc | Composiciones de aminoácidos para el tratamiento de enfermedad hepática |
CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
JP2021527670A (ja) | 2018-06-20 | 2021-10-14 | アクセラ・ヘルス・インコーポレイテッドAxcella Health Inc. | 筋肉中の脂肪浸潤の治療のための組成物及び方法 |
US11679089B2 (en) | 2018-06-20 | 2023-06-20 | Axcella Health Inc. | Methods of manufacturing amino acid compositions |
US20230293459A1 (en) * | 2020-08-06 | 2023-09-21 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Oleylcysteineamide or derivatives thereof and their use in therapy |
US20220218640A1 (en) * | 2021-01-14 | 2022-07-14 | Rob Dickerman | Amino acid delivery system |
US11931127B1 (en) * | 2021-04-08 | 2024-03-19 | T-Mobile Usa, Inc. | Monitoring users biological indicators using a 5G telecommunication network |
TW202315605A (zh) | 2021-07-26 | 2023-04-16 | 美商胺細拉健康公司 | 用於治療covid—19急性後期後遺症的胺基酸組合物及方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4438144A (en) * | 1980-07-31 | 1984-03-20 | Blackburn George L | Amino acid preparation and therapy for treatment of stress and injury |
US20050107338A1 (en) * | 2003-11-17 | 2005-05-19 | Seidman Michael D. | Nutritional supplement enhancing mitochondrial function |
CA2601895C (fr) * | 2005-03-21 | 2014-06-10 | Abbott Laboratories | Composition d'acides amines pour ameliorer la tolerance au glucose |
CN101693740B (zh) * | 2009-10-16 | 2011-09-07 | 中国人民解放军第四军医大学 | Homer1蛋白及其在治疗或预防脑损伤疾病中的应用 |
EP2670403B1 (fr) * | 2011-02-04 | 2021-08-18 | Hough Ear Institute | Méthodes de traitement de lésions cérébrales |
WO2012125020A1 (fr) * | 2011-03-14 | 2012-09-20 | N.V. Nutricia | Méthode de traitement d'un traumatisme neurologique |
US20130090356A1 (en) * | 2011-06-24 | 2013-04-11 | Jon D. Kaiser | Compositions and methods for treatment of neuropsychological deficits |
CA2799127C (fr) * | 2012-12-18 | 2021-05-18 | Matthew Bennett | Compositions et methodes pour traiter une lesion cerebrale traumatique |
EP2986113B1 (fr) * | 2013-04-16 | 2020-08-26 | The Children's Hospital of Philadelphia | Compositions et méthodes pour le traitement des lésions cérébrales |
CN106361738A (zh) * | 2016-08-25 | 2017-02-01 | 南通大学 | 治疗、预防脑白质损伤的医药组合物及其医药用途 |
US20180133185A1 (en) * | 2016-11-11 | 2018-05-17 | The Children's Hospital Of Philadelphia | Compositions and Methods for the Improvement of Memory |
JOP20190146A1 (ar) * | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
JOP20190147A1 (ar) * | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات |
-
2018
- 2018-08-14 CA CA3072092A patent/CA3072092A1/fr not_active Abandoned
- 2018-08-14 TW TW107128277A patent/TW201919602A/zh unknown
- 2018-08-14 KR KR1020207007011A patent/KR20200040276A/ko not_active Application Discontinuation
- 2018-08-14 JO JOP/2020/0035A patent/JOP20200035A1/ar unknown
- 2018-08-14 SG SG11202001131TA patent/SG11202001131TA/en unknown
- 2018-08-14 US US16/103,200 patent/US20190046486A1/en not_active Abandoned
- 2018-08-14 MA MA050155A patent/MA50155A/fr unknown
- 2018-08-14 MX MX2020001766A patent/MX2020001766A/es unknown
- 2018-08-14 AU AU2018318091A patent/AU2018318091A1/en not_active Abandoned
- 2018-08-14 PE PE2020000251A patent/PE20200748A1/es unknown
- 2018-08-14 JP JP2020507989A patent/JP7370960B2/ja active Active
- 2018-08-14 CN CN201880065642.6A patent/CN111295186A/zh active Pending
- 2018-08-14 BR BR112020002244-6A patent/BR112020002244A2/pt not_active Application Discontinuation
- 2018-08-14 WO PCT/US2018/046659 patent/WO2019036442A1/fr unknown
- 2018-08-14 EP EP18762716.1A patent/EP3684350A1/fr active Pending
-
2020
- 2020-01-29 IL IL272336A patent/IL272336A/en unknown
- 2020-02-13 CO CONC2020/0001627A patent/CO2020001627A2/es unknown
- 2020-02-14 CL CL2020000383A patent/CL2020000383A1/es unknown
-
2023
- 2023-07-07 JP JP2023112589A patent/JP2023145496A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CL2020000383A1 (es) | 2020-08-28 |
TW201919602A (zh) | 2019-06-01 |
WO2019036442A1 (fr) | 2019-02-21 |
WO2019036442A9 (fr) | 2020-02-13 |
CN111295186A (zh) | 2020-06-16 |
PE20200748A1 (es) | 2020-07-24 |
CO2020001627A2 (es) | 2020-06-09 |
JP2020530843A (ja) | 2020-10-29 |
JOP20200035A1 (ar) | 2020-02-13 |
EP3684350A1 (fr) | 2020-07-29 |
CA3072092A1 (fr) | 2019-02-21 |
AU2018318091A8 (en) | 2020-03-12 |
JP7370960B2 (ja) | 2023-10-30 |
MX2020001766A (es) | 2020-07-29 |
US20190046486A1 (en) | 2019-02-14 |
IL272336A (en) | 2020-03-31 |
JP2023145496A (ja) | 2023-10-11 |
KR20200040276A (ko) | 2020-04-17 |
AU2018318091A1 (en) | 2020-02-13 |
SG11202001131TA (en) | 2020-03-30 |
BR112020002244A2 (pt) | 2020-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA50155A (fr) | Acides aminés à chaîne ramifiée pour le traitement d'une lésion neuronale | |
MA49906A (fr) | Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie | |
MA55697A (fr) | Molécules d'anticorps pour le traitement du cancer | |
MA45539A (fr) | Dihydropyranopyrimidines pour le traitement d'infections virales | |
MA45037A (fr) | Polythérapie à base d'arnm pour le traitement du cancer | |
MA45192A (fr) | Traitement d'association | |
MA45052A (fr) | Polynucléotides codant pour jagged1 pour le traitement du syndrome d'alagille | |
MA49144A (fr) | Polythérapies pour le traitement du cancer | |
MA45050A (fr) | Polynucléotides codant pour la lipoprotéine lipase destinés au traitement de l'hyperlipidémie | |
MA45481A (fr) | Utilisation d'exosomes pour le traitement de maladies | |
MA49760A (fr) | Mavacamten destiné à être utilisé dans le traitement de la cardiomyopathie hypertrophique | |
MA47719A (fr) | Esketamine pour le traitement de la dépression | |
MA48637A (fr) | Polythérapies pour le traitement du cancer | |
MA50409A (fr) | Polythérapies pour le traitement du cancer | |
MA54925A (fr) | Compositions pour le traitement de troubles acido-basiques | |
MA50849A (fr) | Substances et procédés pour le traitement d'hémoglobinopathies | |
MA46608A (fr) | Formulation liposomale destinée à être utilisée dans le traitement du cancer | |
MA44864A (fr) | Trithérapie pour le traitement d'une maladie intestinale inflammatoire | |
MA42999A (fr) | Polythérapie pour le traitement de malignités | |
MA45054A (fr) | Conjugués médicament-anticorps dll3 pour le traitement de tumeurs à risque de transition neuroendocrinienne | |
MA49393A (fr) | Poly(phosphoesters) destinés à l'administration d'acides nucléiques | |
MA43170A (fr) | Association d'un inhibiteur de bcl-2 et d'un inhibiteur de mek pour le traitement du cancer | |
MA43800A (fr) | Octréotide par voie orale pour le traitement de maladies | |
MA46086A (fr) | Schéma posologique pour le traitement de tumeurs solides | |
MA43825A (fr) | Schémas posologiques pour le traitement d'infections fongiques |